BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
about
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@en
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@nl
type
label
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@en
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@nl
prefLabel
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@en
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@nl
P2093
P2860
P50
P356
P1433
P1476
BCR-ABL1 transcript levels at ...... ous tyrosine kinase inhibitors
@en
P2093
Dong-Wook Kim
Eun-Jung Jang
Hayeon Noh
Jangik I Lee
Ji-Hyung Suh
Ki-Hoon Kang
Kyung-Mi Kee
Mi-Young Lee
Seon-Young Yang
Soo Young Choi
P2860
P304
P356
10.1002/CAM4.1753
P407
P577
2018-08-31T00:00:00Z